Related Experiment Video
Updated: Aug 6, 2026
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 25, 2008
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM --A RAPIDLY EVOLVING ENTITY. CASE REPORT
Insights
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive leukemia primarily affecting the skin. This case highlights its presentation as rapidly growing, ulcerated tumors in a 56-year-old male.
Area of Science:
- Hematology
- Dermatology
- Oncology
Background:
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN), previously termed blastic NK-cell lymphoma, is a rare hematologic malignancy.
- This neoplasm is characterized by aggressive behavior, extranodal involvement (especially skin), and a poor prognosis, predominantly affecting elderly males.
- BPDCN originates from plasmacytoid dendritic cells and presents a diagnostic challenge due to its rarity and varied clinical manifestations.
Observation:
- A previously healthy 56-year-old man presented with a rapidly progressing skin eruption.
- The eruption manifested as multiple, large, painless, ulcerated dermal tumors on the trunk and scalp.
- Initial physical examination revealed no abnormalities other than the extensive skin lesions.
Findings:
- Histopathological examination of a skin biopsy was crucial for diagnosis.
- Immunohistochemical studies demonstrated positivity for CD4, CD45, CD56, CD68, and Ki-67.
- These findings confirmed the diagnosis of blastic plasmacytoid dendritic cell neoplasm.
Implications:
- This case underscores the importance of considering BPDCN in the differential diagnosis of unusual cutaneous tumors.
- Accurate and timely diagnosis through histopathology and immunohistochemistry is critical for appropriate patient management.
- Further research into BPDCN pathogenesis and treatment strategies is warranted given its aggressive nature and poor outcomes.
Abstract:
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), CD4+/CD56+hematodermic neoplasm was formally known as blastic NK-cell lymphoma. It is in fact a form of acute myeloid leukemia notable for highly aggressive behavior with cutaneous, lymph node and bone marrow involvement. This entity is derived from plasmocytoid dendritic cells and has a predilection for extranodal sites, especially the skin. Elderly male patients are the most affected and the prognostic is poor. The first case was reported in 1994 and sice then, single cases and a few small series have been published. This article presents the case of a previously healthy 56-years-old man, who presented himself to a skin eruption consisting in multiple, large dermal ulcerated tumors, located on the trunk and scalp. The lesions were painless and grew in size rapidly. Physical examination was normal except for the skin lesions. Histological examination of a biopsy specimen and immunohistochemical studies (positive for next markers: CD4, CD 45, CD56, CD68, Ki 67) revealed the rare diagnostic-blastic plasmacytoid dendritic cell neoplasm.
More Related Videos
13:34Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
08:01Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
Published on: November 4, 2016
